157 related articles for article (PubMed ID: 25862730)
1. Impairment of quality of life in patients with antiphospholipid syndrome.
Zuily S; Rat AC; Regnault V; Kaminsky P; Mismetti P; Ninet J; Baillet N; Magy-Bertrand N; Pasquali JL; Lambert M; Pasquier E; Lorcerie B; Lecompte T; Guillemin F; Wahl D;
Lupus; 2015 Oct; 24(11):1161-8. PubMed ID: 25862730
[TBL] [Abstract][Full Text] [Related]
2. Thrombovascular events affect quality of life in patients with systemic lupus erythematosus.
Balitsky AK; Peeva V; Su J; Aghdassi E; Yeo E; Gladman DD; Urowitz MB; Fortin PR
J Rheumatol; 2011 Jun; 38(6):1017-9. PubMed ID: 21362766
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid (Hughes) syndrome: description of population and health-related quality of life (HRQoL) using the SF-36.
Georgopoulou S; Efraimidou S; MacLennan SJ; Ibrahim F; Cox T
Lupus; 2015 Feb; 24(2):174-9. PubMed ID: 25239925
[TBL] [Abstract][Full Text] [Related]
4. Health-Related Quality of Life in Antiphospholipid Syndrome: Current Knowledge and Future Perspectives.
Desnoyers M; Dufrost V; Wahl D; Zuily S
Curr Rheumatol Rep; 2020 May; 22(6):20. PubMed ID: 32405870
[TBL] [Abstract][Full Text] [Related]
5. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
[TBL] [Abstract][Full Text] [Related]
6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
8. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
10. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
[TBL] [Abstract][Full Text] [Related]
11. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C;
BMC Immunol; 2017 Mar; 18(1):17. PubMed ID: 28351341
[TBL] [Abstract][Full Text] [Related]
12. Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus.
Calderón J; Flores P; Aguirre JM; Valdivia G; Padilla O; Barra I; Scoriels L; Herrera S; González A; Massardo L
Scand J Rheumatol; 2017 Jul; 46(4):273-280. PubMed ID: 27701937
[TBL] [Abstract][Full Text] [Related]
13. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age.
Rinaldi S; Doria A; Salaffi F; Ermani M; Iaccarino L; Ghirardello A; Zampieri S; Sarzi-Puttini P; Gambari PF; Perini G
Rheumatology (Oxford); 2004 Dec; 43(12):1574-9. PubMed ID: 15353611
[TBL] [Abstract][Full Text] [Related]
15. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
16. Influence of social support on health-related quality of life in patients with systemic lupus erythematosus.
Zheng Y; Ye DQ; Pan HF; Li WX; Li LH; Li J; Li XP; Xu JH
Clin Rheumatol; 2009 Mar; 28(3):265-9. PubMed ID: 19002545
[TBL] [Abstract][Full Text] [Related]
17. The relationship between social support and health-related quality of life in patients with antiphospholipid (hughes) syndrome.
Georgopoulou S; Efraimidou S; MacLennan SJ; Ibrahim F; Cox T
Mod Rheumatol; 2018 Jan; 28(1):147-155. PubMed ID: 28463088
[TBL] [Abstract][Full Text] [Related]
18. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
19. Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus.
Benitha R; Tikly M
Clin Rheumatol; 2007 Jan; 26(1):24-9. PubMed ID: 16538390
[TBL] [Abstract][Full Text] [Related]
20. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.
Wolfe F; Michaud K; Li T; Katz RS
J Rheumatol; 2010 Feb; 37(2):296-304. PubMed ID: 20032098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
